Oncology PracticeFDA pushes for more diversity in clinical trials in draft guidanceJuly 11, 2019Practice ManagementBusiness of Medicine
Oncology PracticeFDA approves bevacizumab-bvzr for several cancersJune 28, 2019Gynecologic CancerRenal Cell CarcinomaLung CancerGastroenterologyGenitourinary CancerCNS/Brain CancerNeuro-oncology
Hematology NewsDaratumumab wins new indication for newly diagnosed myeloma patientsJune 28, 2019Multiple MyelomaLymphoma & Plasma Cell Disorders
Hematology NewsFDA expands Doptelet approval to ITP patients with thrombocytopeniaJune 27, 2019Bleeding DisordersThrombosis
Oncology PracticeFDA approves trastuzumab-anns for HER2-positive breast, gastric cancerJune 14, 2019Breast CancerGastroenterologyGastrointestinal Cancer
Oncology PracticeThe costs of surviving cancerJune 7, 2019Practice ManagementPatient & Survivor CareBusiness of Medicine
Hematology NewsFDA approves first drug for steroid-refractory acute GVHDMay 30, 2019Cellular TherapyPatient & Survivor CareTransplantTransplantation
Hematology NewsFDA approves lenalidomide/rituximab for previously treated FL, MZLMay 29, 2019B Cell LymphomaLymphoma & Plasma Cell DisordersIndolent LymphomaFollicular Lymphoma
Hematology NewsFDA: Faulty hematology analyzers face class I recallMay 24, 2019Bleeding DisordersAnemiaThrombosis
Hematology NewsFDA approves venetoclax/obinutuzumab combo for CLLMay 15, 2019CLLB Cell LymphomaLeukemia, Myelodysplasia, Transplantation
